Abbvie Inc

NYSE: ABBV
$202.72
+$1.42 (+0.7%)
Closing Price on March 27, 2025

ABBV Stock Chart and Intraday Price

ABBV Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 316,039.17M USD
Shares Outstanding 1,766,470,000
Abbvie Inc. is a global pharmaceutical company that focuses on discovering, developing, manufacturing, and selling a wide range of treatments. Its portfolio includes therapies for autoimmune diseases, various cancers, eye diseases, neurological disorders, and more. Notable products include Humira for autoimmune conditions, Skyrizi and Rinvoq for skin and joint diseases, and Imbruvica for blood cancers. AbbVie also offers products in aesthetics, women's health, and eye care. Founded in 2012 and based in North Chicago, Illinois, AbbVie collaborates with several biotech firms to advance its research in oncology and immunology.

ABBV Articles

In the 2020s, there are plenty of yield-focused exchange traded funds (ETFs) to choose from, and they’re not all created equal. Two popular dividend funds in particular — the Schwab U.S. Dividend...
Forget the old adage “it takes money to make money.” In the stock market, even a measly $500 can kickstart a fortune. Time, not a fat wallet, is the real MVP here. With the right picks, that...
If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t ring a bell.  Denner is the CEO and CIO of Sarissa Capital Management, a Greenwich-based...
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
One solid idea for growth and income investors who want to stay invested but shift to a more balanced approach is to look at the incredible Dividend Kings.
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
Shares of AbbVie (NYSE:ABBV) are surging 7% this morning after the pharmaceutical giant reported solid fourth quarter earnings as two key immunology drugs continue to enjoy significant support....
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Some of the best stocks for income investors are the Dividend Kings. Here are five that are perfect for retired baby boomers now.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Donald Trump’s victory is positive for the stock...
Companies with high dividend yields are relatively uncommon in this market. In fact, the average yield on the S&P 500 (albeit one which is heavily weighted toward tech stocks) is around 1.2%. So,...
24/7 Wall St. Insights: AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are now questioning the pharma’s pipeline, raising...
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.55, payable on Tuesday Oct. 15th. While investors will wait to hear about quarterly earnings on Oct....
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.